Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/92375
Citations
Scopus Web of ScienceĀ® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorJones, S.-
dc.contributor.authorDuncan, J.-
dc.contributor.authorAitken, S.-
dc.contributor.authorCoxon, J.-
dc.contributor.authorAbell, A.-
dc.date.issued2014-
dc.identifier.citationAustralian Journal of Chemistry: an international journal for chemical science, 2014; 67(9):1257-1263-
dc.identifier.issn0004-9425-
dc.identifier.issn1445-0038-
dc.identifier.urihttp://hdl.handle.net/2440/92375-
dc.description.abstractRing closing metathesis and cross metathesis approaches to a new macrocyclic peptidomimetic aldehyde 2 have been developed, with the former route being the most convenient. Aldehyde 2 is a potent inhibitor of calpain II (IC50 of 45 nM) with comparable activity to the benchmark acyclic inhibitor SJA6017 4. Both compounds contain an N-terminal 4-fluorophenylsulfonyl group. The P2 Ile analogue of 2 (16) is significantly less active (IC50 of 2000 nM) which reflects an unusually subtle importance of the P2 residue for active site binding.-
dc.description.statementofresponsibilitySeth A. Jones, Joanna Duncan, Steven G. Aitken, James M. Coxon and Andrew D. Abell-
dc.language.isoen-
dc.publisherCSIRO-
dc.rightsCopyright status unknown-
dc.source.urihttp://dx.doi.org/10.1071/ch14121-
dc.titleThe preparation of macrocyclic calpain inhibitors by ring closing metathesis and cross metathesis-
dc.typeJournal article-
dc.identifier.doi10.1071/CH14121-
dc.relation.grantARC-
pubs.publication-statusPublished-
dc.identifier.orcidAbell, A. [0000-0002-0604-2629]-
Appears in Collections:Aurora harvest 7
IPAS publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.